42例丁苯酞胶囊治疗急性脑梗死临床观察  

CLINICAL OBSERVATION ON THE TREATMENT OF 42 CASES OF ACUTE CEREBRAL INFARCTION WITH BUTYL BENZENE PHTHALOCYANINE CAPSULE

作　　者：古联[1] 

机构地区：[1]广西中医学院第一附属医院神经内科,南宁530023

出　　处：《现代预防医学》2011年第22期4792-4793,共2页Modern Preventive Medicine

基　　金：广西壮族自治区卫生厅重点课题(200933);广西教育厅立项课题(200911LX203)

摘　　要：[目的]探讨丁苯酞胶囊治疗急性脑梗死的疗效。[方法]将84例急性脑梗死患者随机分入治疗组和对照组各42例,对照组采用西医常规治疗,治疗组在西医常规治疗的基础上加用丁苯酞胶囊,治疗1个疗程后,观察两组的临床疗效。[结果]治疗组显效率(61.90%)明显高于对照组(38.10%),差异有统计学意义(P﹤0.05),每个组治疗后神经功能缺损程度评分均明显低于治疗前(P﹤0.05),治疗后,治疗组神经功能缺损程度评分(11.03±9.95)显著低于对照组(16.62±10.21)(P﹤0.05)。[结论]丁苯酞胶囊可提高急性脑梗死临床疗效。[Objective]To study the therapeutic effect of butyl benzene phthalocyanine capsule in treating acute cerebral infarction.[Methods]84 patients were divided into therapy group（42 cases）and control group（42 cases）randomly.Conventional therapy was adopted to control group and butyl benzene phthalocyanine capsule was additional to therapy group.Clinical therapeutic effect was observed after 1 month therapy respectively.[Results]The obvious effective rate of therapy group（61.90%）was higher than that of control group（38.10%）（P﹤0.05）.In each group,the neurologic impairment score after therapy was lower than that before therapy significantly（P﹤0.05）.After therapy,the neurologic impairment score of therapy group（11.03 ± 9.95）was lower than that of control group（16.62 ± 10.21）（P﹤0.05）.[Conclusion]Benzene Phthalocyanine Capsule can improve the clinical therapeutic effect of acute cerebral infarction.

关 键 词：急性脑梗死 丁苯酞胶囊 神经功能缺损程度评分 

分 类 号：R743.33[医药卫生—神经病学与精神病学]